Science Explorer Interactive view Map
Nonprofit · San Carlos · United States

Go2 for Lung Cancer

go2.orgROR OpenAlex
Research works
72
▲ 252% vs 2013–17
Citations
161
2.3 per fractional work
Top-10% rate
2.2%
record average 16.5%
Open access
57%
world 28%

Not ranked overall: Go2 for Lung Cancer is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

What does Go2 for Lung Cancer specialise in?

Where its research is concentrated relative to its size: Medicine takes 3.9× the share of its output that it takes of world research.

  1. MedicineField · 27.6 works3.9×
  2. Health SciencesDomain · 29.9 works3.5×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.39× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.13× its world share, 0 worksImmunology and Micro…Engineering: 0.01× its world share, 0 worksEngineeringEnvironmental Science: 0.21× its world share, 0 worksEnvironmental ScienceMathematics: 0.38× its world share, 0 worksMathematicsHealth Professions: 1.96× its world share, 2 worksHealth ProfessionsMedicine: 3.86× its world share, 28 worksMedicineNursing: 1.82× its world share, 0 worksNursingEconomics, Econometrics and Finance: 5.62× its world share, 4 worksEconomics, Econometr…Social Sciences: 0.31× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 5.6×. Every wedge is a field page.

Which keywords describe research at Go2 for Lung Cancer?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Chemotherapy, Targeted Therapy, Risk Factors, Cancer Incidence, Radiotherapy, Population-Based Study and Preventive Services.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Clinical Trials8▲ 33×6 topics
  2. Chemotherapy7▲ 26×8 topics
  3. Targeted Therapy6▲ 77×3 topics
  4. Risk Factors5▲ 12×3 topics
  5. Cancer Incidence4▲ 82×3 topics
  6. Radiotherapy4▲ 29×3 topics
  7. Population-Based Study4▲ 166×2 topics
  8. Preventive Services4▲ 182×2 topics
  9. Global Surveillance4▲ 224×1 topic
  10. Mortality Rates4▲ 109×1 topic
  11. ALK Inhibitors4▲ 157×1 topic
  12. EGFR Mutations4▲ 157×1 topic
  13. Adjuvant Therapy4▲ 74×2 topics
  14. Cost of Care4▲ 311×1 topic
  15. Financial Toxicity4▲ 311×1 topic
  16. CT Screening3▲ 137×1 topic
  17. Lung Cancer3▲ 54×1 topic
  18. Precision Medicine3▲ 18×5 topics
  19. Biomarkers3▲ 11×3 topics
  20. Quality of Life3▲ 5.2×3 topics
  21. Ethical Considerations3▲ 21×2 topics
  22. Immunotherapy3▲ 9.7×2 topics
  23. Machine Learning3▲ 2.2×2 topics
  24. Medical Imaging3▲ 14×2 topics
  25. Prognostic Factors3▲ 16×3 topics
  26. Genomic Profiles2▲ 157×1 topic
  27. Health-related Quality of Life2▲ 29×2 topics
  28. Small-Cell Lung Cancer2▲ 157×1 topic
  29. Cancer Survivorship2▲ 83×2 topics
  30. Health Care Costs2▲ 72×2 topics
  31. End-of-Life2▲ 62×1 topic
  32. Palliative Care2▲ 35×1 topic
  33. Quantitative Analysis2▲ 28×1 topic
  34. Radiomics2▲ 49×1 topic
  35. Depression2▲ 6.2×1 topic
  36. Patient-Reported Outcomes2▲ 103×1 topic
  37. Community Engagement1▲ 10×2 topics
  38. Informed Consent1▲ 43×1 topic
  39. Research Participation1▲ 124×1 topic
  40. Medical Education1▲ 12×3 topics

Which research topics does Go2 for Lung Cancer publish most on?

By volume in 2022–2025: Global Cancer Incidence and Screening, Lung Cancer Treatments and Mutations, Economic and Financial Impacts of Cancer and Lung Cancer Diagnosis and Treatment.

Global Cancer Incidence …4Global Cancer Incidence and Screening: 4 fractional worksLung Cancer Treatments a…4Lung Cancer Treatments and Mutations: 4 fractional worksEconomic and Financial I…4Economic and Financial Impacts of Cancer: 4 fractional worksLung Cancer Diagnosis an…3Lung Cancer Diagnosis and Treatment: 3 fractional worksLung Cancer Research Studies: 2 fractional worksRadiomics and Machine Learning in Medical Imaging: 2 fractional worksPalliative Care and End-…2Palliative Care and End-of-Life Issues: 2 fractional worksCancer survivorship and care: 2 fractional worksEthics in Clinical Research: 1 fractional worksCOVID-19 and healthcare impacts: 1 fractional works
OncologyPulmonary and Respiratory MedicineEconomics and EconometricsRadiology, Nuclear Medicine and Imaging1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Global Cancer Incidence and Screening Oncology 4 works
  2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
  3. 3 Economic and Financial Impacts of Cancer Economics and Econometrics 4 works
  4. 4 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 3 works
  5. 5 Lung Cancer Research Studies Oncology 2 works
  6. 6 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works
  7. 7 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 2 works
  8. 8 Cancer survivorship and care Oncology 2 works
  9. 9 Ethics in Clinical Research Public Health, Environmental and Occupational Health 1 works
  10. 10 COVID-19 and healthcare impacts Oncology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available57.1%not open42.9%

World: 28% of research is openly available.

with international co-authors15.5%domestic only84.5%

World: 19% is written across borders.

How has Go2 for Lung Cancer's research output changed?

Output in 2018–2022 was 252% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Carlos

All research institutions in San Carlos

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.